GLP-1 drugs enable safe weight loss before hernia repair with better surgical outcomes | Research

The takeaway

GLP-1 receptor agonists achieved clinically significant preoperative weight loss in obese hernia patients, enabling surgical candidacy and potentially improving outcomes through prehabilitation.

New bridge to surgery
GLP-1 drugs enable obese patients to achieve preoperative weight goals for safer hernia repair—converting surgical ineligibility to eligibility

What the researchers found

GLP-1RAs achieved clinically significant preoperative weight loss in obese hernia patients. Enabled surgical candidacy for previously ineligible patients. Potential to reduce obesity-related surgical complications.

Why it matters

Many obese patients are denied hernia repair due to high complication risk. GLP-1 drugs provide the first effective pharmacological bridge to safe surgery, addressing a common clinical impasse.

How the study worked

Retrospective study examining GLP-1RA use for preoperative weight optimization before abdominal wall hernia repair.

What this study cannot tell us

Retrospective. Specific weight loss amounts not detailed in preview. Long-term surgical outcomes not assessed. Small sample likely.

How to read the evidence

Retrospective study. Early evidence for a novel application.

When this study was published

Published in 2025.

The bigger picture

This extends GLP-1 drug applications into perioperative medicine, where preoperative weight optimization can reduce surgical risk. The concept is applicable to many elective surgeries where obesity increases complications.

Questions still open

How much weight loss is needed before hernia repair?
Does preoperative GLP-1 use affect anesthesia or perioperative management?
Should this approach be standardized for all obese surgical candidates?

Common questions

Why is weight loss important before hernia surgery?

Obesity increases risks of hernia recurrence, wound infection, and other complications after repair. By using GLP-1 drugs to lose weight before surgery, patients can reduce these risks and improve their chances of a successful outcome.

Can I use semaglutide before surgery?

This study supports using GLP-1 drugs for preoperative weight loss in hernia repair. However, GLP-1 drugs also slow stomach emptying, which can affect anesthesia. Discuss timing and management with your surgical and anesthesia team.

Read the original research

The new bridge to hernia surgery: achieving preoperative weight optimization with GLP-1 receptor agonists for abdominal wall hernia repair.

Surgical endoscopy, 39(8), 5296-5302

View on PubMed ↗Publisher’s paper ↗

Citation

Spurzem, Graham J; Broderick, Ryan C; Ruiz-Cota, Patricia; Rocha, Amanda; Reyes, Edgardo; Fontaine-Nicola, Andres; Altolaguirre, Agustina; Hollandsworth, Hannah M; Sandler, Bryan J; Grunvald, Eduardo; Jacobsen, Garth R. (2025). The new bridge to hernia surgery: achieving preoperative weight optimization with GLP-1 receptor agonists for abdominal wall hernia repair.. Surgical endoscopy, 39(8), 5296-5302. https://doi.org/10.1007/s00464-025-11921-z